Trans-nasal Endoscopy for Bariatric Patients
Use of Sedation-Free Transnasal Endoscopy to Improve Access and Lower Costs of Endoscopic Evaluations in a Bariatric Medical and Surgical Program
Christopher C. Thompson, MD, MSc
100 participants
Apr 1, 2026
INTERVENTIONAL
Conditions
Summary
This study plans to learn if the EvoEndo Endoscopy system can be used to evaluate, provide and follow up care for upper gastrointestinal tract diseases in the bariatric population. The smallest current scope available for such a technique is an adult transnasal endoscope with a larger diameter, a pulmonary bronchoscope or Ear Nose and Throat (ENT) laryngoscope. This study is evaluating a newly Food and Drug Administration (FDA) cleared ultra-slim, single-use, endoscope specifically designed for transnasal endoscopy to evaluate its use in adult upper tract gastrointestinal diseases. If such a technique is successful it could improve the safety, cost, and access of endoscopic care for patients in need of an endoscopic evaluation for a bariatric medical condition.
Eligibility
Inclusion Criteria2
- Patient 18 years of age and less than 90 years of age with clinically referred for esophagoscopy, gastroscopy, or esophagogastroduodenoscopy (EGD)
- Cared for in metabolic and bariatric clinic
Exclusion Criteria3
- Patient \<18 years of age
- Medically contraindicated to perform EGD or TNE
- Inability to provide informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Unsedated endoscopic evaluation through the nose.
Sedated endoscopic evaluation through the mouth.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06200961